European Archives - Page 119 of 1264 - European Medical Journal

A collection of illustrated lab equipment

UK’s 10 Year Health Plan pledges clinical trial overhaul

The UK government has set out a 10 Year Health Plan, promising to transform clinical trials and make the UK a scientific superpower.

Genetic Variants Linked to Early-Onset Lung Cancer in Asian Populations

New research links TP53, BRCA2, and ALKBH2 mutations to early-onset lung cancer in Asian women who have never smoked.

EHA 2025: Circulating Tumour Cells Offer Prognostic Insight in Multiple Myeloma

A large European analysis confirms circulating tumour cells (CTCs) as an independent prognostic biomarker in newly diagnosed multiple myeloma.

Simple Measurement May Help Prevent Diabetic Foot Ulcer Relapse

Learn how high TEWL after healing is linked to twice the risk of DFU recurrence.

Hereditary Angioedema Prevalence Underestimated, Study Suggests

Discover a study where findings suggest that previous estimates may have underrepresented the true HAE population by excluding HAE-nl-C1INH.

Trial Confirms Efficacy of Elobixibat for Chronic Constipation

Understand how short-term use of elobixibat significantly boosts bowel movements in chronic constipation.

Non-Diabetic Metabolic Dysfunction Increases Liver Fibrosis Risk

This study explored the effects of various metabolic abnormalities, such as central obesity, high blood pressure, and elevated high-sensitivity C-reactive protein (hsCRP), on liver steatosis and fibrosis.

Healthy Lifestyle May Mitigate Telomere-Linked Brain Disease Risk

Healthy lifestyle choices could reduce the risk of stroke, dementia, and late-life depression in individuals with biologically shorter telomeres.

Lower Socioeconomic Status Linked to Hidradenitis Suppurativa

Compared to patients from the highest SES quintile, those in the lowest quintile had over three times the odds of being diagnosed with hidradenitis suppurativa.

New Monoclonal Antibody Cuts Bronchiolitis Admissions in Young Infants

Early evidence shows that nirsevimab substantially reduced emergency bronchiolitis cases and hospital admissions in infants under 6 months.